Kazimierz Kuliczkowski
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 35
- Chronic Myeloid Leukemia Treatments 23
- Multiple Myeloma Research and Treatments 22
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 46
- Myeloproliferative Neoplasms: Diagnosis and Treatment 18
- Immunology top 2%
- Oncology top 2%
-
- Lymphoma Diagnosis and Treatment 40
-
- Acute Lymphoblastic Leukemia research 19
-
- Angiogenesis and VEGF in Cancer 14
- Co-authors
- Grzegorz MazurDariusz WołowiecTomasz WróbelBruno QuesnelValérie CoiteuxDominique HétuinAbdelbasset HamrouniJizhong Liu
- Cited by
- HematologyGeneticsImmunology
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (6 papers)Blood (22 papers)
- Partner nations
- PolandUnited StatesUnited Kingdom
In The Last Decade
Kazimierz Kuliczkowski
197 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Hematology 1.2k
- Genetics 1.1k
- Immunology 978
- Oncology 1.2k
- Pathology and Forensic Medicine 794
Countries citing papers authored by Kazimierz Kuliczkowski
This map shows the geographic impact of Kazimierz Kuliczkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazimierz Kuliczkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazimierz Kuliczkowski more than expected).
Fields of papers citing papers by Kazimierz Kuliczkowski
This network shows the impact of papers produced by Kazimierz Kuliczkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazimierz Kuliczkowski. The network helps show where Kazimierz Kuliczkowski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazimierz Kuliczkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2016 | 13 | |
| 3 | Ofatumumab (O) in combination with fludarabine (F) and cyclophosphamide (C) (OFC) vs. FC in patients with relapsed chronic lymphocytic leukaemia (CLL): results of the phase III study complement 2 | 2015 | 3 |
| 4 | 2014 | 30 | |
| 5 | ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population | 2011 | 1 |
| 6 | Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin’s lymphoma | 2011 | 2 |
| 7 | AL Amyloidosis (Amyloidosis Antibody Light). Part 2 – Epidemiology, Clinical Symptoms, Diagnosis and Treatment of Amyloidosis AL | 2011 | 1 |
| 8 | 2011 | 19 | |
| 9 | Efficacy and safety of bortezomib-rituximab (VCR) vs rituximab® in patients (PTS) with relapsed, R-naive/-sensitive follicular lymphoma (FL): outcome according to prior therapy | 2011 | 1 |
| 10 | 2011 | 31 | |
| 11 | FCGR3A polymorphism does not significantly affect response and outcome of follicular lymphoma patients treated in the PRIMA study with rituximab and chemotherapy followed by rituximab maintenance or observation | 2011 | 1 |
| 12 | A european observational study of dasatinib in the management of imatinib-resistant and -intolerant patients with chronic myeloid leukemia: forte study (ca180-211) | 2010 | 1 |
| 13 | Fungal Contamination of Air in the Department of Haematology | 2010 | 1 |
| 14 | Human Pim-2 Gene Expression in Acute Myeloid and Acute Lymphoblastic Leukemia Patients and Complete Remission | 2010 | 1 |
| 15 | 2009 | 24 | |
| 16 | Expression of CD105 Antigen in Patients with Acute Leukemia, Malignant Lymphoma, and Multiple Myeloma in Active Phase of the Disease | 2006 | 1 |
| 17 | Effect of Exogenous Melatonin on Rat Haematopoietic Cells Exposed to Cytosine Arabinoside and Etoposide | 2006 | 1 |
| 18 | Macrophage/histiocytic antigen CD68 expression in neoplastic and reactive lymph nodes. | 2004 | 5 |
| 19 | [Anagrelide in the treatment of thrombocythemia essential (ET)]. | 2004 | 4 |
| 20 | 2004 | 14 |
About Kazimierz Kuliczkowski
Kazimierz Kuliczkowski is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 202 papers that have together received 3.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (46 papers), Lymphoma Diagnosis and Treatment (40 papers), Acute Myeloid Leukemia Research (35 papers), Chronic Myeloid Leukemia Treatments (23 papers), Multiple Myeloma Research and Treatments (22 papers), Acute Lymphoblastic Leukemia research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers) and Angiogenesis and VEGF in Cancer (14 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (1.1k citations) and Immunology (978 citations). Kazimierz Kuliczkowski has collaborated with scholars based in Poland, United States and United Kingdom. Frequent co-authors include Grzegorz Mazur, Dariusz Wołowiec, Tomasz Wróbel, Bruno Quesnel, Valérie Coiteux, Dominique Hétuin, Abdelbasset Hamrouni, Jizhong Liu, Aurore Saudemont and Justyna Rybka. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.